These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1317544)

  • 1. Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists.
    Miaskowski C; Sutters KA; Taiwo YO; Levine JD
    Pain; 1992 Apr; 49(1):137-144. PubMed ID: 1317544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
    Miaskowski C; Levine JD
    Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic synergy and improved motor function produced by combinations of mu-delta- and mu-kappa-opioids.
    Sutters KA; Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1990 Oct; 530(2):290-4. PubMed ID: 1979930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the rat.
    Miaskowski C; Sutters KA; Taiwo YO; Levine JD
    Brain Res; 1991 Jul; 553(1):105-9. PubMed ID: 1933267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociception produced by receptor selective opioids. Modulation of supraspinal antinociceptive effects by spinal opioids.
    Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1993 Apr; 608(1):87-94. PubMed ID: 8388314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
    Bot G; Chahl LA; Brent PJ; Johnston PA
    Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats.
    Hoffman DC; West TE; Wise RA
    Brain Res; 1991 Jun; 550(2):205-12. PubMed ID: 1653084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa- and delta-opioid agonists synergize to produce potent analgesia.
    Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1990 Feb; 509(1):165-8. PubMed ID: 2155044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Green SA; Gebhart GF
    Pain; 1995 Oct; 63(1):39-47. PubMed ID: 8577489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
    Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
    Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of spinal opioid analgesia by supraspinal administration of selective opioid antagonists.
    Miaskowski C; Levine JD
    Brain Res; 1992 Nov; 596(1-2):41-5. PubMed ID: 1361418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats.
    Jackson HC; Kitchen I
    Psychopharmacology (Berl); 1989; 97(3):404-9. PubMed ID: 2541460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of antinociceptive and motor effects of supraspinal opioid agonists in the rat.
    Franck LS; Miaskowski C; Putris J; Levine JD
    Brain Res; 1991 Nov; 563(1-2):123-6. PubMed ID: 1664771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
    Bhargava HN; Cao YJ; Zhao GM
    Brain Res; 1997 Mar; 752(1-2):234-8. PubMed ID: 9106462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
    Murray CW; Cowan A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.